Analystreport

Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Oramed Pharmaceuticals Inc.  (ORMP) 
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm Check Earnings Report
US:NASDAQ Investor Relations: oramed.com/investors